Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› miR-124
miR-124
(1 companies · 2 programs)
Companies with an active program directed at miR-124.
Abivax S.A.
ABVX
obefazimod
— Ulcerative Colitis
Phase 3
obefazimod
— Crohn's Disease
Phase 2